Countering Captagon and Narcotics Post-Assad Act
- Bill Number
- H.R. 7180
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- International Affairs
- Status
- Introduced
- Latest Action
- 2026-01-21: Referred to the House Committee on Foreign Affairs.
- Last Updated
- 2026-02-11T13:46:33Z
AI-Generated Summary
Purpose
This legislation, titled the "Countering Captagon and Narcotics Post-Assad Act," aims to update an existing U.S. government strategy to address the production and trafficking of Captagon (a synthetic drug similar to amphetamines), methamphetamine, and other amphetamine-type stimulants in the Middle East. It focuses on adapting to changes following the fall of the Assad regime in Syria, emphasizing threats to regional stability and U.S. interests, and promoting coordinated efforts to disrupt these illegal networks.
Key Provisions
- Updated Findings: Revises the foundational statements in the strategy to highlight how shifts in drug production and trafficking patterns after the Assad regime's collapse—especially in Iraq—could threaten regional stability and U.S. security. It also notes that Captagon contributes to broader instability in the Middle East, particularly in Syria.
- Strategy Requirements: Mandates an unclassified, written interagency strategy (developed by the Departments of Defense, State, Justice, Treasury, and Homeland Security) to counter narcotics in the Middle East. The strategy must include:
- Identification of countries receiving or transiting large shipments of these drugs.
- Evaluation of those countries' abilities to stop smuggling, trafficking, and production.
- Review of current U.S. aid and training programs to build counter-narcotics capabilities in those countries.
- Assessment of partnerships with international allies to target drug infrastructure.
- Specific recommendations to dismantle networks, including those connected to the former Assad regime, Hezbollah (a militant group), and Iran-backed proxies (groups supported by Iran).
Significant Changes to Existing Law
This bill amends Section 1238 of the National Defense Authorization Act for Fiscal Year 2023, which originally focused on a strategy targeting narcotics linked specifically to the Assad regime. Key updates include:
- Broadening the scope from Assad-linked activities to all narcotics production and trafficking in the Middle East.
- Requiring the strategy to be unclassified (previously unspecified), making it more publicly accessible.
- Expanding the strategy's content to include detailed assessments of drug patterns in the U.S. Central Command's area (covering the Middle East and Central Asia) and adding recommendations targeting additional actors like Hezbollah and Iran-backed groups.
- Renaming references to align with this bill's title.
Potential Impacts
- On Government Agencies: U.S. agencies involved in defense, foreign affairs, law enforcement, finance, and homeland security will need to collaborate more closely on assessments, training programs, and international partnerships, potentially increasing resource allocation for counter-narcotics efforts.
- On Citizens: Indirect benefits for U.S. citizens through enhanced regional stability, reduced drug flows that could affect global markets, and protection of American interests abroad; no direct impact on domestic citizens mentioned.
- On International Relations: Could strengthen U.S. ties with Middle Eastern countries by offering aid and training to build their counter-drug capacities, while escalating tensions with groups like Hezbollah and Iran through targeted disruptions. It may encourage more multilateral cooperation to secure borders and combat trafficking.
Main Stakeholders Affected
- U.S. Government Agencies: Departments of Defense, State, Justice, Treasury, and Homeland Security, which must develop and implement the updated strategy.
- Middle Eastern Countries: Nations in the U.S. Central Command area (e.g., Iraq, Syria, and transit countries) receiving U.S. assistance to enhance their counter-narcotics efforts.
- International Partners: Allies cooperating on disrupting drug networks, potentially including regional governments and organizations.
- Adversarial Groups: Former Assad regime elements, Hezbollah, and Iran-backed proxies, whose narcotics operations are targeted for dismantling.
- Broader Affected Parties: Communities in drug-producing or transit areas facing instability from trafficking, and global populations impacted by the spread of synthetic drugs like Captagon.
Notable Legal, Constitutional, or Political Implications
- Legal: Reinforces existing authorities under national defense and foreign policy laws without creating new enforcement powers; emphasizes unclassified reporting, which promotes transparency but may limit sensitive details on operations.
- Constitutional: Aligns with Congress's role in overseeing foreign affairs and national security (Article I, Section 8), ensuring interagency coordination without infringing on executive branch functions.
- Political: Signals a U.S. policy shift toward proactive counter-narcotics in the post-Assad Middle East, potentially influencing diplomatic negotiations and sanctions. It highlights bipartisan concern (introduced by representatives from both parties) over drug-fueled instability, but could draw criticism for focusing on specific geopolitical actors like Iran and Hezbollah, affecting U.S. credibility in the region.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Rep. Moskowitz, Jared [D-FL-23]
Recent Actions
- 2026-01-21: Referred to the House Committee on Foreign Affairs.
- 2026-01-21: Introduced in House
- 2026-01-21: Introduced in House
Bill Versions
- Countering Captagon and Narcotics Post-Assad Act — issued 2026-01-21 — PDF (4 pages)